Thus, in vitro experiments have shown that IFN-β treatment induced CXCL10 expression of melanoma cells [58] and DCs stimulated with IFNα/IFN-β produced significant amounts of CXCL9 and CXCL10 [41]. This evidence concerns the gene CXCL9 and melanoma.